Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study ; volume:20 ; number:1 ; day:23 ; month:4 ; year:2022 ; pages:1-10 ; date:12.2022
World journal of surgical oncology ; 20, Heft 1 (23.4.2022), 1-10, 12.2022
- Urheber
-
Javed, Sahir
Benoist, Stéphane
Devos, Patrick
Truant, Stéphanie
Guimbaud, Rosine
Lièvre, Astrid
Sefrioui, David
Cohen, Romain
Artru, Pascal
Dupré, Aurélien
Bachet, Jean-Baptiste
Fouchardière, Christelle de la
Ploquin, Anne
Turpin, Anthony
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12957-022-02594-2
- URN
-
urn:nbn:de:101:1-2022070619001484579528
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Javed, Sahir
- Benoist, Stéphane
- Devos, Patrick
- Truant, Stéphanie
- Guimbaud, Rosine
- Lièvre, Astrid
- Sefrioui, David
- Cohen, Romain
- Artru, Pascal
- Dupré, Aurélien
- Bachet, Jean-Baptiste
- Fouchardière, Christelle de la
- Ploquin, Anne
- Turpin, Anthony
- SpringerLink (Online service)
Ähnliche Objekte (12)
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer
BRAF V600E -mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
BRAF V600E Metastatic Colorectal Cancer: Perspective from a Patient, a Caregiver, and an Oncologist
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Nachweis der BRAF-V600E-Mutation beim metastasierten kolorektalen Karzinom : : ein QuIP-Ringversuch = Detection of BRAF V600E mutation in metastatic colorectal carcinoma : a QuIP round robin test
Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report
BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer
BRAF V600E -mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
BRAF V600E Metastatic Colorectal Cancer: Perspective from a Patient, a Caregiver, and an Oncologist
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Nachweis der BRAF-V600E-Mutation beim metastasierten kolorektalen Karzinom : : ein QuIP-Ringversuch = Detection of BRAF V600E mutation in metastatic colorectal carcinoma : a QuIP round robin test
Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report
BRAF V600E mutation and KRAS codon 13 mutations predict poor survival in Chinese colorectal cancer patients
BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAF V600E colorectal cancer
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF V600E metastatic colorectal cancer
BRAF V600E -mutated serrated colorectal neoplasia drives transcriptional activation of cholesterol metabolism
BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report
BRAF V600E Metastatic Colorectal Cancer: Perspective from a Patient, a Caregiver, and an Oncologist
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated
Nachweis der BRAF-V600E-Mutation beim metastasierten kolorektalen Karzinom : : ein QuIP-Ringversuch = Detection of BRAF V600E mutation in metastatic colorectal carcinoma : a QuIP round robin test
Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens
Validierung eines Protokolls zur manuellen, mutationsspezifischen BRAF V600E Immunhistochemie
Molecular profiling of BRAF-V600E-mutant metastatic colorectal cancer in the phase 3 BEACON CRC trial
BRAF Non-V600E Mutated Metastatic Colorectal Cancer in a Young Patient: Discussion from a Case Report